Skip To The Main Content

Pharmacopoeia Conference

May 16 - May 17, 2019
Geneva, Switzerland

The 2nd Annual PDA Conference on International Developments in the Pharmacopoeial Landscape

  • Conference
  • Europe

left to register

Program Highlights

Final Agenda Published!

Review the updated brochure and make sure to be part of this program!


Dear Colleagues,

At the 2018 inaugural conference, representatives from globally recognized pharmacopoeias shared their authorities' and organisations’ approaches to international convergence, harmonization & the future direction of pharmacopoeias with respect to the overall framework of regulations and guidelines.

This resulted in valuable discussion and exchange and generated momentum we now intend to use and continue our efforts to delve deeper into issues relevant to manufacturers of active pharmaceutical ingredients, excipients and medicinal products.

Please be invited to submit a paper or poster abstract for presentation and contribute your professional insights, views and best-practices in the effective and efficient implementation of international pharmacopoeial requirements.

We look forward to welcoming you to beautiful Geneva, Switzerland next May!

Best Regards,

Susanne Keitel,
PhD, EDQM, Chair

Nadine Ritter,
PhD, Global Biotech Experts, Co-Chair


  • Day 1
  • Day 2
  • Thursday, 16 May 2019

    9:00 – 9:10
    Welcome and Introduction
    Falk Klar, PDA Europe
    Susanne Keitel, EDQM,Conference Chair
    Nadine Ritter, Global Biotech Experts, Conference Co-Chair

    9:10 – 13:15
    Session 1: Working Principles of Pharmacopoeias in Their Regulatory Framework
    Nadine Ritter,
    Global Biotech Experts
    Janeen Skutnik-Wilkinson,

    9:10 – 9:40
    The Ph. Eur.: A Successful Example of How a Pharmacopoeia Supports and Fosters Implementation of Regulatory Texts
    Susanne Keitel, EDQM

    9:40 – 10:10
    Ensuring Quality of Medicines: Role of USP Standards
    Jaap Venema, USP

    10:10 – 10:40
    Japanese Pharmacopoeia
    Tsuyoshi Ando, PMDA

    10:40 –11:10
    Coffee Break, Poster Session & Exhibition

    11:10 – 11:40
    Brazilian Pharmacopoeia:
    Working Principles and regulatory Framework

    Riviane Matos Gonçalves, ANVISA

    11:40 – 12:10
    Place and Role of the Indian Pharmacopoeia Commission in
    Promoting Quality and Safety of Medicines

    Manisha Trivedi, IPC

    12:10 – 12:40
    WHO Updates: International Perspective
    Sabine Kopp, WHO

    12:40 – 13:15
    Panel Discussion with International Representatives

    13:15 –14:15 
    Lunch Break, Poster Session & Exhibition

    14:15 – 16:00
    Session 2: Introductions to Breakout Session
    Moderator: Susanne Keitel,

    Each of these talks will introduce the audience to the three topics Analytics, Biotherapeutics, and Manufacturing before each of these will be addressed in more detail during the afternoon roundtable discussions.

    14:15 – 14:45
    Analytical QbD and the Pharmacopoeia
    James Pound, MHRA

    14:45 – 15:15
    Evolution of the Compendial Landscape – Product Specific Monographs for Biotherapeutics
    Mihaela Buda, EDQM
    Joseph A. Albanese, Janssen, J&J

    15:15 – 15:45
    Continuous Manufacture of Drug Products and Drug Substances
    Andrew Rutter, GSK
    Graham Cook, Pfizer on behalf of EFPIA

    15:45 – 16:15 
    Coffee Break, Poster Session & Exhibition

    16:15 – 17:45
    Breakout Sessions – Roundtable Discussions

    Attendees are free to choose two out of the three topics offered, engaging in discussions for 45 minutes each.

    James Pound,
    Vinny Browning,
    Interchangeability and Validation of Analytical Methods, Acceptance Criteria, QbD, etc

    Nadine Ritter,
    Global Biotech Experts
    Mihaela Buda,
    ATMPs, Monoclonal Antibodies, Biosimilars / Biobetters, etc.

    Graham Cook,
    Cathie Vielle,
    Continuous Manufacturing, PAT, Control of Impurities, etc.

    Brief Summary of Highlights from Roundtables

    End of Day 1 and Networking Event

  • Friday, 17 May 2019


    9:00 – 12:00
    Session 3A: Reference Standards – Manufacture and Characterization
    Moderator: Vinny Browning,

    9:00 – 9:30
    Use of Compendial Reference Standards for Instrument Qualification and Method Validation
    Stefan Almeling, EDQM

    9:30 – 10:00
    Latest Developments in USP Biologics Performance Standards
    Kevin Carrick, USP

    10:00 – 10:30
    Coffee Break, Poster Session & Exhibition

    10:30 – 11:00
    Bioassay International Standards for Monoclonal Antibodies: New Reagents for New Challenges
    Sandra Prior, NIBSC

    11:00 – 11:30
    Compendial Equivalence of In-house Reference Standards - Learnings and Key Challenges of the Process
    Aoife Mee, Novartis

    11:30 – 12:00
    Q&A, Discussion

    9:00 – 12:00
    Session 3B: Practical Examples of Monitoring, Assessment and Implementation of Pharmacopoeial Changes
    Moderator: Frithjof Holtz,

    9:00 – 9:30
    Case Study: A Process for Monitoring and Engaging with Pharmacopoeias
    Janeen Skutnik Wilkinson, Biogen

    9:30 – 10:00
    Compendial Compliance in a Global Environment: Process Optimization for Pharmacopoeia Review
    J. Mark Wiggins, Global Pharmacopoeia Solutions

    10:00 – 10:30
    Coffee Break, Poster Session & Exhibition

    10:30 – 11:00
    Case Study of Particulate Matter in Biopharmaceutical Drug Products – Leveraging Working Groups and White Papers
    Jan Stracke, Hoffmann-La Roche

    11:00 –12:00
    Q&A, Panel Discussion

    12:00 – 13:00
    Lunch Break, Poster Session & Exhibition

    13:00 – 16:30
    Session 4: Process for Prioritization in Convergence of Monographs and Maintenance of Convergent Status
    Moerator: Paolo Tozzi,

    13:00 – 13:30
    An Effective Process for Monitoring, Assessing, and Implementing Compendial Changes at a Global Pharmaceutical Company
    Matthew Borer, Eli Lilly

    13:30 – 14:00
    Bilateral Working Principles: Harmonization Efforts
    Philip Travis, Pfizer on behalf of EFPIA

    14:00 – 14:30
    Update on Recent PDG Developments and the New Maintenance Procedure on the ICH Q4B Annexes Adopted by the ICH Assembly
    Cathie Vielle, EDQM

    14:30 – 15:00
    Q&A, Panel Discussion

    15:00 – 15:30
    Lunch Break, Poster Session & Exhibition

    15:30 – 16:00
    Closing Keynote – Overview, Future Perspectives
    Joint Reflection from Pharmacopoeia & Industry

    Susanne Keitel, EDQM
    Graham Cook, Pfizer

    16:00 – 16:30
    Closing Remarks
    Susanne Keitel, EDQM,Conference Chair
    Nadine Ritter, Global Biotech Experts, Conference Co-Chair
    Falk Klar, PDA Europe

Highlighted Speakers

Tsuyoshi Ando
Tsuyoshi Ando
PMDA, Japanese Pharmacopeia
Kevin Carrick
Kevin Carrick
United States Pharmacopoeia
Sabine Kopp
Sabine Kopp
World Health Organization
Riviane Matos Gonçalves
Riviane Matos Gonçalves
Brazilian Health Regulatory Agency
Sandra Prior
Sandra Prior
Andrew Rutter
Andrew Rutter
Jaap Venema
Jaap Venema
United States Pharmacopoeia (USP)
Cathie Vielle
Cathie Vielle

Additional Information

  • Who Should Attend

    More information coming soon.

Got a Question? We have answers

Contact Us


PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.

Crowne Plaza Geneva

Avenue Louis Casai 75-77
Geneva, Switzerland
Phone: +41 (0) 22 710 30 29

Crowne Plaza Geneva
  • Accommodations

    Hotel Website

    Renovated and re-designed in 2014, the Crowne Plaza Geneva is within a 3-minute drive of Geneva Airport and the Palexpo Exhibition Center, and only a 10-minute drive from the city center. The hotel offers a free shuttle service from and to the airport.

    The hotel, with a Club floor on the top floor, offering panoramic views of the surroundings also offers its guests a complimentary breakfast, refreshments, snacks and a large selection of newspapers and books.

    A bus stop and a taxi stand are right in front of the hotel. A free card for public transport is available at the reception. The hotel is only a 4-minute drive from the Balexert, Geneva's largest shopping mall.

    PDA Europe has reserved a limited number of rooms until the 5th April 2019.
    Book Your Room for the PDA Group Rate

    Single Room CHF 235 per night, VAT, Taxes and Service Charges will apply*
    Double Room CHF 265 per night, VAT, Taxes and Service Charges will apply*

    *Rates are per room and night, including the following:
    • Buffet Breakfast in the restaurant
    • Wireless Internet Connection (WI-FI)
  • Amenities

How to Get Here

By Air

Nearest Airport: Geneva Airport - GVA, known as Cointrin Airport
Airport Phone:
+41 22 717 71 11

By Car

1.4 km, 3 min by car. The Crowne Plaza Geneva is located at Avenue Louis Casai 75-77, Geneva 1216.

Other Options

Free shuttle bus between airport and hotel.

Train station: Cointrin.

Subway station: De Joinville bus stop.


Registration Fees

Early Registration
Registration Type Price by 17 March
Member €1.695
Non-member €1.995
Govern./Health Authority/Academic €750

Regular Registration
Registration Type Price after 17 March
Member €1.895
Non-member €2.195
Govern./Health Authority/Academic €850

All fees given in Euro and excluding VAT (21%)

Group Registration Discount: Register 3 people from the same organization as a group (at the same time) for the event and receive the 4th registration free. Other discounts cannot be applied.

GENERAL TERMS AND CONDITIONS: PDA will send you a confirmation letter within one week of payment being received. You must have this confirmation letter to be considered enrolled in a PDA event. If you have submitted a purchase order or requested an invoice, please be advised that a credit card guarantee is needed. PDA reserves the right to modify the material or speakers/trainers without notice or to cancel an event. If an event is cancelled, registrants will be notified by PDA immediately and will receive a credit (registration fee paid). PDA will not be responsible for any costs incurred by registrants due to cancellation. Please note that the attendee list is shared with attendees, trainers, and exhibitors and may be used to follow up on specific areas of interest after the event. Video, photo, and audio recordings are prohibited at all PDA events.

CANCELLATION: If a cancellation request is received 30 days before the event, a credit (registration fee paid minus a 200.00 USD/EUR processing fee) will be given. No credits will be given for cancellation requests received less than 30 days before the event. Cancellation requests must be emailed to [email protected].


Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information

Featured Exhibitors

Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information

Media Partners


Program Inquiries
Exhibition Inquiries
Training Course Inquiries

Tel: +1 (301) 656-5900
[email protected]

Tel: +49 (0) 30 43 655 08-10
[email protected]

Registration Customer Care

Tel: +1 (301) 656-5900 ext. 115
[email protected]

PDA Members Save Substantially